August 9, 2022
Pfizer on August 8 filed an application seeking Japanese regulatory approval for its Omicron-adapted bivalent mRNA vaccine for COVID-19 being developed with BioNTech, the company said. The new jab is based on the ancestral strain of the novel coronavirus and...read more